These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 10850413

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. FHITness and cancer.
    Druck T, Berk L, Huebner K.
    Oncol Res; 1998; 10(7):341-5. PubMed ID: 10063967
    [Abstract] [Full Text] [Related]

  • 23. Positions of chromosome 3p14.2 fragile sites (FRA3B) within the FHIT gene.
    Zimonjic DB, Druck T, Ohta M, Kastury K, Croce CM, Popescu NC, Huebner K.
    Cancer Res; 1997 Mar 15; 57(6):1166-70. PubMed ID: 9067288
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Frequent abnormalities of the putative tumor suppressor gene FHIT at 3p14.2 in pancreatic carcinoma cell lines.
    Simon B, Bartsch D, Barth P, Prasnikar N, Münch K, Blum A, Arnold R, Göke B.
    Cancer Res; 1998 Apr 15; 58(8):1583-7. PubMed ID: 9563464
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Ectogenous fragile histidine triad gene inhibits the malignant phenotype of human lung cancer cell line A549 in vitro and in vivo].
    Zhang LQ, Wang H, Lai BT, Yue WT, Zhan XP, Yang XH, Zhang CY, Zhang TM.
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 May 15; 28(5):333-6. PubMed ID: 15949315
    [Abstract] [Full Text] [Related]

  • 28. FHIT expression in clear cell renal carcinomas: versatility of protein levels and correlation with survival.
    Ramp U, Caliskan E, Ebert T, Karagiannidis C, Willers R, Gabbert HE, Gerharz CD.
    J Pathol; 2002 Apr 15; 196(4):430-6. PubMed ID: 11920739
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Identification of unstable sequences within the common fragile site at 3p14.2: implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3p14.2 in tumors.
    Corbin S, Neilly ME, Espinosa R, Davis EM, McKeithan TW, Le Beau MM.
    Cancer Res; 2002 Jun 15; 62(12):3477-84. PubMed ID: 12067991
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Restoration of fragile histidine triad (FHIT) expression inhibits cell growth and induces apoptosis in cutaneous T-cell lymphoma cell line.
    Song X, Tian Z, Wang S, Peng Z, Feng J.
    Cancer Invest; 2010 Dec 15; 28(10):1019-23. PubMed ID: 20690795
    [Abstract] [Full Text] [Related]

  • 33. [Allelic loss and down-regulation of FHIT gene expression in esophageal squamous cell carcinoma].
    Liu FX, Huang XP, Zhao CX, Xu X, Han YL, Cai Y, Wu RL, Wu M, Zhan QM, Wang MR.
    Ai Zheng; 2004 Sep 15; 23(9):992-8. PubMed ID: 15363189
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Absence of Fhit protein in primary lung tumors and cell lines with FHIT gene abnormalities.
    Sozzi G, Tornielli S, Tagliabue E, Sard L, Pezzella F, Pastorino U, Minoletti F, Pilotti S, Ratcliffe C, Veronese ML, Goldstraw P, Huebner K, Croce CM, Pierotti MA.
    Cancer Res; 1997 Dec 01; 57(23):5207-12. PubMed ID: 9393735
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Structure and expression of the human FHIT gene in normal and tumor cells.
    Druck T, Hadaczek P, Fu TB, Ohta M, Siprashvili Z, Baffa R, Negrini M, Kastury K, Veronese ML, Rosen D, Rothstein J, McCue P, Cotticelli MG, Inoue H, Croce CM, Huebner K.
    Cancer Res; 1997 Feb 01; 57(3):504-12. PubMed ID: 9012482
    [Abstract] [Full Text] [Related]

  • 39. Components of DNA damage checkpoint pathway regulate UV exposure-dependent alterations of gene expression of FHIT and WWOX at chromosome fragile sites.
    Ishii H, Mimori K, Inageta T, Murakumo Y, Vecchione A, Mori M, Furukawa Y.
    Mol Cancer Res; 2005 Mar 01; 3(3):130-8. PubMed ID: 15798093
    [Abstract] [Full Text] [Related]

  • 40. Molecular and cellular characterization of human renal cell carcinoma cell lines.
    Anglard P, Trahan E, Liu S, Latif F, Merino MJ, Lerman MI, Zbar B, Linehan WM.
    Cancer Res; 1992 Jan 15; 52(2):348-56. PubMed ID: 1345811
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.